Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
The Vitiligo and Pigmentation Institute of Southern California is a world-renowned center of excellence specializing in the treatment and research of pigmentary disorders. Founded and led by Dr. Pearl E. Grimes, the institute provides advanced clinical care for conditions such as vitiligo, melasma, and hyperpigmentation. In addition to patient care, the institute serves as a premier clinical research site, participating in numerous Phase 1 through Phase 4 clinical trials for leading pharmaceutical and biotechnology companies. Its dual focus on innovative dermatological procedures and rigorous scientific research has established it as a global leader in pigmentary health and aesthetic dermatology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vitiligo and Pigmentation Institute of Southern California.